Literature DB >> 4529735

Mode of action of chemotherapy in vivo on human acute leukemia--II. Vincristine.

P A Stryckmans, P M Lurie, J Manaster, G Vamecq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4529735     DOI： 10.1016/0014-2964(73)90002-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.

Authors:  A T McGown; D G Poppitt; R Swindell; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.

Authors:  D G Poppitt; A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 3.  Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy.

Authors:  S O'Reilly; M J Kennedy; E K Rowinsky; R C Donehower
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.

Authors:  Kevin J Pollard; Brad Bolon; Michael J Moore
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

5.  Bilateral optic neuropathy following vincristine chemotherapy: A case report with description of multimodal imaging findings.

Authors:  Woo Hyuk Lee; Sun Kyoung You; Yeon-Hee Lee
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

6.  Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial).

Authors:  Mirjam Esther van de Velde; Gertjan J L Kaspers; Floor C H Abbink; Jos W R Twisk; Inge M van der Sluis; Cor van den Bos; Marry M van den Heuvel-Eibrink; Heidi Segers; Christophe Chantrain; Jutte van der Werff Ten Bosch; Leen Willems; Marleen H van den Berg
Journal:  Cancers (Basel)       Date:  2020-12-12       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.